Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P I Lobo

Showing results (11-20 of 46) with videos related to

Pageof 5
Sort By:
Journal of Clinical & Laboratory Immunology|February 1, 1979
Reappraisal of lymphocyte subpopulations in sarcoidosis: demonstration of a specific deficiency of L lymphocytesP I Lobo, P M Suratt
The Journal of Clinical Investigation|January 1, 1989
Use of anti-HLA antibodies to mask major histocompatibility complex gene products on tumor cells can enhance susceptibility of these cells to lysis by natural killer cellsP I Lobo, C E Spencer
Journal of Clinical & Laboratory Immunology|February 1, 1979
Studies on the autoantibody to lymphocytes in sarcoidosisP I Lobo, P M Suratt
The Journal of Clinical Investigation|June 1, 1979
Inhibition of humoral and cell-mediated immune responses in man by distinct suppressor cell systemsP I Lobo, C E Spencer
Immunology|October 1, 1994
A novel role for MHC class II antigens: evidence implicating a protective effect on tumour cells against cytotoxicity by NK and LAK cellsP I Lobo, H C Patel
The Journal of Clinical Investigation|December 1, 1975
Characterizaiton of two populations of human lymphocytes bearing easily detectable surface immunoglobulinD A Horwitz, P I Lobo
Journal of Immunological Methods|December 9, 1988
In vitro assays to study role of T cell-derived factors on human B lymphocytes should take into consideration inhibiting effect of large granular lymphocyte subset (CD5-,CD16+) that can contaminate B cell preparationsP I Lobo, A E Wright
Immunology and Cell Biology|June 1, 1997
Murine monoclonal IgG antibodies: differences in their IgG isotypes can affect the antibody effector activity when using human cellsP I Lobo, H C Patel
European Journal of Immunology|August 1, 1982
In vitro studies on the immune regulatory role of complement receptors (C3) present on human B lymphocytesP I Lobo, J J Burge
Arthritis and Rheumatism|June 1, 1978
Significance of anti-lymphocyte antibodies in systemic lupus erythematosusJ B Winfield, P I Lobo, A Singer
Pageof 5

Showing results (11-20 of 46) with videos related to

Sort By:
Pageof 5
Journal of Clinical & Laboratory Immunology|February 1, 1979
Reappraisal of lymphocyte subpopulations in sarcoidosis: demonstration of a specific deficiency of L lymphocytesP I Lobo, P M Suratt
The Journal of Clinical Investigation|January 1, 1989
Use of anti-HLA antibodies to mask major histocompatibility complex gene products on tumor cells can enhance susceptibility of these cells to lysis by natural killer cellsP I Lobo, C E Spencer
Journal of Clinical & Laboratory Immunology|February 1, 1979
Studies on the autoantibody to lymphocytes in sarcoidosisP I Lobo, P M Suratt
The Journal of Clinical Investigation|June 1, 1979
Inhibition of humoral and cell-mediated immune responses in man by distinct suppressor cell systemsP I Lobo, C E Spencer
Immunology|October 1, 1994
A novel role for MHC class II antigens: evidence implicating a protective effect on tumour cells against cytotoxicity by NK and LAK cellsP I Lobo, H C Patel
The Journal of Clinical Investigation|December 1, 1975
Characterizaiton of two populations of human lymphocytes bearing easily detectable surface immunoglobulinD A Horwitz, P I Lobo
Journal of Immunological Methods|December 9, 1988
In vitro assays to study role of T cell-derived factors on human B lymphocytes should take into consideration inhibiting effect of large granular lymphocyte subset (CD5-,CD16+) that can contaminate B cell preparationsP I Lobo, A E Wright
Immunology and Cell Biology|June 1, 1997
Murine monoclonal IgG antibodies: differences in their IgG isotypes can affect the antibody effector activity when using human cellsP I Lobo, H C Patel
European Journal of Immunology|August 1, 1982
In vitro studies on the immune regulatory role of complement receptors (C3) present on human B lymphocytesP I Lobo, J J Burge
Arthritis and Rheumatism|June 1, 1978
Significance of anti-lymphocyte antibodies in systemic lupus erythematosusJ B Winfield, P I Lobo, A Singer
Pageof 5